Objective: To assess the long-term outcomes of multistage surgical approach in 18 surviving patients in areas of mortality, requirement for postoperative interventional cardiac catheterization, saturations on air, right ventricular (RV) pressures in relation to the systemic pressures, RV and left ventricular (LV) functions and the adequacy of pulmonary arborisation. Method: Data of all surviving patients who underwent complete repair at Southampton University Hospital were reviewed. Data were obtained using case notes and computer based patient records. No data were gathered by direct patient contacts. LV and RV ejection fractions were measured by cardiac magnetic resonance imaging. Pulmonary arborisation patterns were assessed using cardiac catheter data. Results: A total of 26 patients had undergone complete repair. There were 8 (30.8%) deaths and the 18 survivors constituted the study group. Eleven (61.1%) had undergone three or more surgeries to attain complete repair. Fifteen (83.3%) maintained resting saturations above 80% after surgery. Nine (50%) had undergone three or more catheter interventions after complete repair. Eleven (61.1%) had undergone one or more pulmonary ballooning. Nine (50%) had undergone pulmonary artery (PA) stenting. Four (22.2%) had a RV ejection fraction (EF) <45% and 5 (27.7%) had a LV EF <45%. Seven (38.8%) had RV pressures >50% of LV pressures. Certain zones of the lungs were significantly under-filled on complete repair. Conclusions: Children with pulmonary atresia, ventricular septal defect and major aortopulmonary collaterals can be treated using a staged repair. There is a high mortality (31%) with average functional results.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.